Post-prandial effects of high-polyphenolic extra virgin olive oil on endothelial function in adults at risk for type 2 diabetes: A randomized controlled crossover trial. (1st May 2021)

• Record Type: Journal Article
• Authors: Njike, Valentine Y.; Ayettey, Rockiy; Treu, Judith A.; Doughty, Kimberly N.; Katz, David L.
• Is Part Of: International journal of cardiology. Volume 330(2021)
• Page Start: 171
• Page End: 176
• Publication Date: 2021-05-01
• Subjects: Endothelial function -- Olive oil -- Cardiovascular disease; Cardiology -- Periodicals; Electronic journals; 616.12
• DOI: 10.1016/j.ijcard.2021.01.062
• Languages: English
• ISSNs: 0167-5273

Abstract

Abstract: Background: Effects of olive oil on cardiovascular risk have been controversial. We compared the effects of high-polyphenolic extra virgin olive oil (EVOO) and refined olive oil without polyphenols on endothelial function (EF) in adults at risk for Type 2 diabetes mellitus (T2DM). Methods: Randomized, controlled, double-blind, crossover trial of 20 adults (mean age 56.1 years; 10 women, 10 men) at risk for T2DM (i.e., as defined by either prediabetes or metabolic syndrome) assigned to one of two possible sequence permutations of two different single dose treatments (50 mL of high-polyphenolic EVOO or 50 mL of refined olive oil without polyphenols), with 1-week washout. Participants received their olive oils in a smoothie consisting of ½ cup frozen blueberries and 1 cup (8 oz) low-fat vanilla yogurt blended together. Primary outcome measure was EF measured as flow-mediated dilatation. Participants were evaluated before and 2 h after ingestion of their assigned olive oil treatment. Results: EVOO acutely improved EF as compared to refined olive oil (1.2 ± 6.5% versus −3.6 ± 3.8%; p = 0.0086). No significant effects on systolic or diastolic blood pressure were observed. Conclusions: High-polyphenolic EVOO acutely enhanced EF in the study cohort, whereas refined olive oil did not. Blood pressure effects were not observed. Reports on the vascular effects of olive oil ingestion should specify the characteristics of the oil. Clinical trial registration number: NCT04025281 Highlights: The effects of the ingestion of olive oil on cardiovascular risk are controversial. Adults at risk for Type 2 Diabetes received either high-polyphenolic extra virgin olive oil (EVOO) or a refined olive oil. The ingestion of a single dose of 50mL (about 58.5g) of high-polyphenolic EVOO improved endothelial function. No effects on blood pressure were observed following the ingestion of either oil. The vascular effects of really 'good' olive oils are beneficial, while those of 'bad' olive oils are not.